Joshua Ezell
Internal Medicine · Overland Park, KSNPI 1851632806
Payments from drug & device makers
Across 188 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$612
- Novo Nordisk$362
- Amgen$297
- Lilly USA, LLC$240
- AstraZeneca$200
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$154
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,976100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $612 |
| Novo Nordisk | 20 | $362 |
| Amgen | 17 | $297 |
| Lilly USA, LLC | 14 | $240 |
| AstraZeneca | 12 | $200 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $154 |
| Pfizer | 9 | $125 |
| Amarin Pharma, Inc. | 8 | $114 |
| Johnson & Johnson | 7 | $100 |
| Bayer | 5 | $79 |
| GSK | 5 | $74 |
| Boston Scientific | 4 | $69 |
| Boehringer Ingelheim | 3 | $47 |
| Esperion Therapeutics, Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Abbott | 2 | $35 |
| Eisai Inc. | 2 | $30 |
| Novartis | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Merck | 2 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $22 |
| Tolmar, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Medtronic | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
| Vifor Pharma, Inc. | 1 | $11 |
| Sumitomo Pharma America, Inc. | 1 | $6 |
How this compares
$2,976 in reported general payments places this provider in the 85th percentile of 705 internal medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $52,177 |
| OzempicSemaglutide | 27 | $34,615 |
| XareltoRivaroxaban | 25 | $15,324 |
| Praluent PenAlirocumab | 14 | $7,956 |
| LinzessLinaclotide | 12 | $6,237 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,911 |
| PaxlovidNirmatrelvir/Ritonavir | 16 | $4,288 |
| Testosterone | 23 | $2,205 |
| SynthroidLevothyroxine Sodium | 21 | $1,909 |
| Atorvastatin Calcium | 91 | $1,121 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,070 |
| Tamsulosin Hcl | 50 | $968 |
| Rosuvastatin Calcium | 65 | $891 |
| Omeprazole | 53 | $851 |
| Levothyroxine Sodium | 66 | $769 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $125 | $56,46555 claims |
| Novo NordiskOzempic | $362 | $34,61527 claims |
| Johnson & JohnsonXarelto | $100 | $15,32425 claims |
| AbbVieLinzess, Synthroid | $612 | $8,14633 claims |
| GSKAnoro Ellipta | $74 | $5,91112 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $76966 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 705 internal medicine providers in Kansas.
Other internal medicine in Overland Park
- Jonathan JacobsOverland Park$827K
- Thomas CuevasOverland Park$382K
- Lisa VansaghiOverland Park$131K
- Herbert WaxmanOverland Park$82K
- Shadrach SmithOverland Park$27K
- David EdalatiOverland Park$21K
- Jennifer BrownOverland Park$9K
- Ammar KhalifaOverland Park$8K
- Bruce SalvaggioOverland Park$8K
- Vijaya SamuelOverland Park$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.